Transcanna creates hemp division; executes LOI with hemp based Biovelle

Transcanna Holdings Inc. (CSE: TCAN) (FSE: TH8) ("TransCanna" or the "Company") is pleased to announce today the execution of a non-binding Letter Of Intent dated April 30th, 2019 to acquire the branding asset package, Biovelle, a hemp based CBD coconut oil from an arm's length third party.

Maharshi Atreya Health Centre - Well known Ayurvedic Health Centre in India

Maharshi Atreya Health Centre is a place of retreat for anyone seeking a genuine holistic experience for the well-being of body and mind. With a focus on authentic Ayurveda combined with today's possibilities of medical sciences, the Ayurvedic health centre offers best alternative to Western medicine.

Hemp, Inc. releases its 2018 Annual Report showing massive revenue increase over previous year

Hemp, Inc. (OTC PINK: HEMP) reported financial results for the quarter and full year ending December, 31, 2018. A global leader in the industrial hemp industry with bi-coastal processing centers including the 85,000 square-foot multipurpose industrial hemp processing facility in Spring Hope, North Carolina, a state of the art processing center in Medford, Oregon, and a 500-acre hemp growing Eco-Village in Golden Valley, Arizona, Hemp, Inc. showed over an 1,800% increase in sales from previous year 2017.

ReShape Lifesciences Announces Distribution in Australia

(ACN Newswire) - ReShape Lifesciences Inc. (OTCQB: RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, today announced that as of April 1, 2019, the company is selling its LAP-BAND(R) product in the Australian market through a relationship with Satori Healthcare.

NutraLife Biosciences encouraged by cVS Health Corporation's decision to distribute CBD at 800 stores in the U.S.

NutraLife Biosciences, Inc. ("the Company" or "NutraLife") (OTCQB: NLBS) notes current trends in the retail space including CVS Health Corp.'s announcement that it will carry products containing CBD derived from hemp in about 800 of its U.S. drugstores.

NutraLife Bioscience, Inc. receives license to grow and process Industrial Hemp

NutraLife Biosciences, Inc. ("the Company" or "NutraLife") (OTCQB: NLBS) has received two licenses from the Wisconsin Department of Agriculture to grow and process industrial hemp within the state. The Company plans to develop efficient, cost reducing growing systems and processing technologies for industrial hemp.

NutraLife Biosciences, Inc. (OTCQB: NLBS) receives contract to provide its technologies and delivery system for Pharmaceutical Products by cGMP Pharmacy

NutraLife Biosciences, Inc. ("the Company" or "NutraLife") (OTCQB: NLBS) announces it has signed an agreement with Orlando Pharmacy, a USP 797 compliant compounding pharmacy, to provide its technologies and an innovative delivery system for pharmaceutical products.

NutraFuels, Inc tests confirm high quality Proprietary Ultra Shear Technology Platform

NutraFuels, Inc (NTFU) and Pressure BioSciences, Inc (PBI), in a joint venture, announce that analytical tests on Hemp-derived CBD oil processed by PBI's Ultra Shear Technology (UST) platform confirm: (i) UST processing results in the development of a true CBD oil nanoemulsion, and (ii) CBD is neither lost nor modified during the UST process (> 99% recovery).

Singapore eDevelopment (SGX:40V) Subsidiary, Global BioLife's 3F Antimicrobial Fragrance Shows Efficacy against Tuberculosis

SINGAPORE, Jan 28, 2019 - (ACN Newswire) - Singapore Exchange-listed Singapore eDevelopment Limited (Stock Code 40V) ("SeD") wishes to announce today that its U.S. biomedical subsidiary, Global BioLife Inc. ("Global BioLife") has a product known as 3F Antimicrobial Fragrance which shows efficacy against tuberculosis.

CD Genomics Claims a discount for most services to celebrate Christmas & new year

CD Genomics announces the launch of Christmas and New Year promotion from December 1st to January 31st. The products in the great promotion include most of its services, such as next-generation sequencing, PacBio SMRT sequencing, genotyping, etc. More importantly, this discount reached amazing 5%.